Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
MEDP

MEDP - Medpace Holdings Inc Stock Price, Fair Value and News

$597.85-4.40 (-0.73%)
Market Closed

60/100

MEDP

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

60/100

MEDP

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$619.22

Target 3M

$595.69

Target 6M

$603.34

MEDP Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MEDP Price Action

Last 7 days

-3.7%

Last 30 days

4.9%

Last 90 days

3.0%

Trailing 12 Months

72.9%

MEDP RSI Chart

MEDP Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MEDP Valuation

Market Cap

16.8B

Price/Earnings (Trailing)

38.89

Price/Sales (Trailing)

7.14

EV/EBITDA

30.27

Price/Free Cashflow

24.88

MEDP Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$619.22

Target 3M

$595.69

Target 6M

$603.34

MEDP Fundamentals

MEDP Revenue

Revenue (TTM)

2.4B

Rev. Growth (Yr)

23.74%

Rev. Growth (Qtr)

9.38%

MEDP Earnings

Earnings (TTM)

433.0M

Earnings Growth (Yr)

15.25%

Earnings Growth (Qtr)

23.13%

MEDP Profitability

EBT Margin

22.02%

Return on Equity

147.46%

Return on Assets

24.7%

Free Cashflow Yield

4.02%

MEDP Investor Care

Buy Backs (1Y)

9.37%

Diluted EPS (TTM)

14.3

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20252.2B2.2B2.4B0
20242.0B2.0B2.1B2.1B
20231.6B1.7B1.8B1.9B
20221.2B1.3B1.4B1.5B
2021955.0M1.0B1.1B1.1B
2020891.1M882.0M896.1M925.9M
2019742.3M786.2M823.2M861.0M
2018492.6M556.5M625.2M704.6M
2017428.6M428.9M431.7M436.2M
2016374.7M390.3M406.0M421.6M
2015000359.1M
20140000
Get all data in R, Python etc through our Historical Stock Data APIs

About Medpace Holdings Inc

MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
 CEO
 WEBSITEmedpace.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES5600

Medpace Holdings Inc Frequently Asked Questions

MEDP is the stock ticker symbol of Medpace Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Medpace Holdings Inc is 16.84 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check MEDP's fair value in chart for subscribers.

The fair value guage provides a quick view whether MEDP is over valued or under valued. Whether Medpace Holdings Inc is cheap or expensive depends on the assumptions which impact Medpace Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MEDP.

As of Wed Jan 28 2026, MEDP's PE ratio (Price to Earnings) is 38.89 and Price to Sales (PS) ratio is 7.14. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MEDP PE ratio will change depending on the future growth rate expectations of investors.